Key Insights

Highlights

Success Rate

63% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 87/100

Termination Rate

21.4%

3 terminated out of 14 trials

Success Rate

62.5%

-24.1% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed with results

Key Signals

1 with results63% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (13)
P 1 (1)

Trial Status

Completed5
Terminated3
Recruiting2
Not Yet Recruiting2
Unknown2

Trial Success Rate

62.5%

Benchmark: 86.6%

Based on 5 completed trials

Clinical Trials (14)

Research Network

Activity Timeline